(Q45401512)

English

Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant (English)

1 reference

Europe PubMed Central

14 December 2017

0 references

Hepatitis B virus

1 reference

based on heuristic

inferred from title

lymphoproliferative disorders

1 reference

based on heuristic

inferred from title

author name string

Münci Yağci

1

1 reference

Europe PubMed Central

14 December 2017

Kadir Acar

2

1 reference

Europe PubMed Central

14 December 2017

Gülsan Türköz Sucak

3

1 reference

Europe PubMed Central

14 December 2017

Kadri Yamaç

4

1 reference

Europe PubMed Central

14 December 2017

Rauf Haznedar

5

1 reference

Europe PubMed Central

14 December 2017

publication date

26 July 2007

1 reference

Europe PubMed Central

14 December 2017

European Journal of Haematology

1 reference

Europe PubMed Central

14 December 2017

79

1 reference

Europe PubMed Central

14 December 2017

4

1 reference

Europe PubMed Central

14 December 2017

292-296

1 reference

Europe PubMed Central

14 December 2017

Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00912.X

21 January 2018

Hepatitis A, hepatitis B, and combination hepatitis vaccines for immunoprophylaxis: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00912.X

21 January 2018

Hepatitis B vaccination in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00912.X

21 January 2018

Two booster dose hepatitis B virus vaccination in patients with leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00912.X

21 January 2018

Efficacy of GM-CSF as an Adjuvant to Hepatitis B Vaccination in Patients with Chronic Renal Failure—Results of a Prospective, Randomized Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00912.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00912.X

21 January 2018

Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00912.X

21 January 2018

Lamivudine therapy for acute hepatitis B infection following peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00912.X

21 January 2018

Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00912.X

21 January 2018

A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00912.X

21 January 2018

Lamivudine treatment failure in preventing fatal outcome of de novo severe acute hepatitis B in patients with haematological diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00912.X

21 January 2018

Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00912.X

21 January 2018

The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00912.X

21 January 2018

Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00912.X

21 January 2018

Identifiers

10.1111/J.1600-0609.2007.00912.X

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45401512&oldid=2076621300"